Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets
Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.
409 Views
Giant Biogene IPO: Valuation First Look
Giant Biogene will launch its US$500 million HKEx IPO this week. In this note, we present our forecasts and take the first look at its potential...
429 Views
Shiseido: China Exposure, Potential Earnings Misses and Write-Offs Create Additional Downside Risk
We think that there’s still considerable downside risk to Shiseido in the short term, especially with the company’s exposure to the worsening China...
351 Views
Giant Biogene Pre-IPO - Thoughts on Valuation
Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.
396 Views
Japanese Cosmetics: Trading Around Q3 Earnings
The latest rally in Japanese cosmetics, driven by improving domestic market conditions has strangely avoided two of the big names in the market,...
316 Views